1. Hypertension during pregnancy can be classified into five main categories: preeclampsia, eclampsia, gestational hypertension, chronic hypertension, and preeclampsia superimposed on chronic hypertension.
2. Gestational hypertension involves new onset high blood pressure after 20 weeks without proteinuria, while preeclampsia includes high blood pressure accompanied by proteinuria.
3. Eclampsia is a complication of preeclampsia involving seizures not caused by other conditions.
Hypertensive disorders in pregnancy refer to a group of conditions characterized by high blood pressure during pregnancy, which can include gestational hypertension (high blood pressure that develops after 20 weeks of pregnancy) and preeclampsia (a more severe form of hypertension that can also cause protein in the urine and changes in liver function). These conditions can be serious for both the mother and the baby and may require close monitoring and management. Treatment options may include medications to lower blood pressure, as well as close monitoring of the mother and baby to ensure their health and well-being.
Pre-Eclampsia and Hypertensive Disease in Pregnancymeducationdotnet
This document discusses pre-eclampsia and hypertensive disease in pregnancy. It begins by outlining normal blood pressure changes during pregnancy and then defines different types of hypertension including chronic hypertension, pregnancy-induced hypertension, and pre-eclampsia. Pre-eclampsia is described as a multi-system disorder specific to pregnancy caused by placental dysfunction. The document details diagnostic criteria, clinical features, complications, investigations, and stepwise management of pre-eclampsia including delivery timing and postpartum care. Management involves treating hypertension, preventing eclampsia with magnesium sulfate if needed, and delivery to cure the condition, balancing risks of preterm birth.
1) The document discusses pregnancy induced hypertension, its classification, diagnosis, and management. It defines four types of hypertensive disorders in pregnancy: gestational hypertension, preeclampsia-eclampsia (mild and severe), superimposed preeclampsia-eclampsia, and chronic (preexisting) hypertension.
2) For diagnosis of hypertension in pregnancy, blood pressure must exceed 140/90 mmHg. Diagnosis of mild or severe preeclampsia depends on blood pressure levels and presence of proteinuria.
3) Management of mild preeclampsia can involve outpatient monitoring with regular visits or inpatient monitoring with maternal and fetal monitoring and treatment if signs worsen.
1) Pregnancy induced hypertension complicates 5-10% of pregnancies and is a leading cause of maternal mortality. It includes gestational hypertension, preeclampsia, and chronic hypertension.
2) Preeclampsia is diagnosed when a woman develops high blood pressure and protein in the urine after 20 weeks of pregnancy. Symptoms can include headaches, abdominal pain, and vision changes.
3) Management of mild preeclampsia involves outpatient monitoring while management of severe preeclampsia requires hospitalization, magnesium sulfate treatment, and sometimes antihypertensive drugs. Delivery is the definitive treatment when the condition becomes severe or the pregnancy reaches term.
This document discusses hypertension in pregnancy. It covers how to measure blood pressure in pregnant women, the diagnostic criteria for gestational hypertension and preeclampsia, risk factors, pathophysiology, tests to run, management including medications and delivery timing, and postpartum care. Preeclampsia is a leading cause of maternal and infant morbidity and mortality whose exact causes remain unknown but may be related to placental dysfunction and an exaggerated maternal inflammatory response.
The document summarizes the management of hypertensive disorders in pregnancy. It defines hypertension and the different types of hypertensive disorders that can occur during pregnancy including gestational hypertension, preeclampsia, eclampsia, chronic hypertension, and preeclampsia superimposed on chronic hypertension. It discusses the risk factors, pathogenesis, clinical manifestations, diagnostic criteria, and management approaches for non-severe and severe preeclampsia, including antihypertensive treatment and seizure prophylaxis.
This document discusses hypertensive disorders in pregnancy, which remain a leading cause of maternal mortality in Uganda. It defines various hypertensive disorders including chronic hypertension, gestational hypertension, preeclampsia, and HELLP syndrome. Risk factors, pathogenesis, clinical features, investigations, and management are described. Severe preeclampsia is treated with antihypertensive drugs like hydralazine to control blood pressure and delivery of the baby to resolve the condition. Hypertensive disorders continue to have high mortality and morbidity rates in Uganda.
Cardiovascular diseases of pregnancy.pptgreatdiablo
This document discusses cardiovascular and respiratory disorders in pregnancy. It provides classifications and definitions for hypertensive disorders in pregnancy including gestational hypertension, preeclampsia, eclampsia, chronic hypertension, and HELLP syndrome. It discusses the pathophysiology, evaluation, management, and treatment of these conditions. It also discusses respiratory disorders like asthma and influenza that can occur during pregnancy.
Hypertensive disorders in pregnancy refer to a group of conditions characterized by high blood pressure during pregnancy, which can include gestational hypertension (high blood pressure that develops after 20 weeks of pregnancy) and preeclampsia (a more severe form of hypertension that can also cause protein in the urine and changes in liver function). These conditions can be serious for both the mother and the baby and may require close monitoring and management. Treatment options may include medications to lower blood pressure, as well as close monitoring of the mother and baby to ensure their health and well-being.
Pre-Eclampsia and Hypertensive Disease in Pregnancymeducationdotnet
This document discusses pre-eclampsia and hypertensive disease in pregnancy. It begins by outlining normal blood pressure changes during pregnancy and then defines different types of hypertension including chronic hypertension, pregnancy-induced hypertension, and pre-eclampsia. Pre-eclampsia is described as a multi-system disorder specific to pregnancy caused by placental dysfunction. The document details diagnostic criteria, clinical features, complications, investigations, and stepwise management of pre-eclampsia including delivery timing and postpartum care. Management involves treating hypertension, preventing eclampsia with magnesium sulfate if needed, and delivery to cure the condition, balancing risks of preterm birth.
1) The document discusses pregnancy induced hypertension, its classification, diagnosis, and management. It defines four types of hypertensive disorders in pregnancy: gestational hypertension, preeclampsia-eclampsia (mild and severe), superimposed preeclampsia-eclampsia, and chronic (preexisting) hypertension.
2) For diagnosis of hypertension in pregnancy, blood pressure must exceed 140/90 mmHg. Diagnosis of mild or severe preeclampsia depends on blood pressure levels and presence of proteinuria.
3) Management of mild preeclampsia can involve outpatient monitoring with regular visits or inpatient monitoring with maternal and fetal monitoring and treatment if signs worsen.
1) Pregnancy induced hypertension complicates 5-10% of pregnancies and is a leading cause of maternal mortality. It includes gestational hypertension, preeclampsia, and chronic hypertension.
2) Preeclampsia is diagnosed when a woman develops high blood pressure and protein in the urine after 20 weeks of pregnancy. Symptoms can include headaches, abdominal pain, and vision changes.
3) Management of mild preeclampsia involves outpatient monitoring while management of severe preeclampsia requires hospitalization, magnesium sulfate treatment, and sometimes antihypertensive drugs. Delivery is the definitive treatment when the condition becomes severe or the pregnancy reaches term.
This document discusses hypertension in pregnancy. It covers how to measure blood pressure in pregnant women, the diagnostic criteria for gestational hypertension and preeclampsia, risk factors, pathophysiology, tests to run, management including medications and delivery timing, and postpartum care. Preeclampsia is a leading cause of maternal and infant morbidity and mortality whose exact causes remain unknown but may be related to placental dysfunction and an exaggerated maternal inflammatory response.
The document summarizes the management of hypertensive disorders in pregnancy. It defines hypertension and the different types of hypertensive disorders that can occur during pregnancy including gestational hypertension, preeclampsia, eclampsia, chronic hypertension, and preeclampsia superimposed on chronic hypertension. It discusses the risk factors, pathogenesis, clinical manifestations, diagnostic criteria, and management approaches for non-severe and severe preeclampsia, including antihypertensive treatment and seizure prophylaxis.
This document discusses hypertensive disorders in pregnancy, which remain a leading cause of maternal mortality in Uganda. It defines various hypertensive disorders including chronic hypertension, gestational hypertension, preeclampsia, and HELLP syndrome. Risk factors, pathogenesis, clinical features, investigations, and management are described. Severe preeclampsia is treated with antihypertensive drugs like hydralazine to control blood pressure and delivery of the baby to resolve the condition. Hypertensive disorders continue to have high mortality and morbidity rates in Uganda.
Cardiovascular diseases of pregnancy.pptgreatdiablo
This document discusses cardiovascular and respiratory disorders in pregnancy. It provides classifications and definitions for hypertensive disorders in pregnancy including gestational hypertension, preeclampsia, eclampsia, chronic hypertension, and HELLP syndrome. It discusses the pathophysiology, evaluation, management, and treatment of these conditions. It also discusses respiratory disorders like asthma and influenza that can occur during pregnancy.
This document discusses hypertension in pregnancy, including gestational hypertension and preeclampsia. It defines the different categories of hypertension in pregnancy, describes the pathophysiology and risk factors, and outlines treatment and management approaches. Key points include that hypertension complicates 8% of pregnancies and is a leading cause of maternal mortality. Gestational hypertension is defined as hypertension after 20 weeks in a previously normotensive woman that resolves by 12 weeks postpartum, while preeclampsia involves hypertension and proteinuria. Early onset of gestational hypertension or higher blood pressure levels increase the risk of progression to preeclampsia. Treatment focuses on controlling blood pressure, preventing seizures with magnesium sulfate, and timely delivery.
Gestational hypertension is defined as hypertension occurring for the first time after 20 weeks of pregnancy with NO proteinuria or other features of preeclampsia.
The correct answer is 4.
Hypertension in pregnancy can be gestational hypertension, chronic hypertension, or chronic hypertension appearing for the first time in pregnancy. Gestational hypertension is high blood pressure without proteinuria after 20 weeks of gestation. Pre-eclampsia includes gestational hypertension plus proteinuria. Eclampsia involves seizures in pre-eclamptic women. The pathophysiology involves placental lesions restricting blood flow and damaging the endothelium, affecting multiple maternal organs. Management involves monitoring, controlling blood pressure, delivering if complications occur, and magnesium sulfate to prevent seizures in eclampsia.
Hypertensive disorder during pregnancy.pptxMesfinShifara
1. Gestational hypertension is defined as new hypertension after 20 weeks without proteinuria. It is managed as an outpatient by monitoring blood pressure and fetal wellbeing.
2. Preeclampsia is defined as new hypertension and proteinuria after 20 weeks. It is classified as preeclampsia without or with severe features. Severe features include headaches, visual disturbances, abdominal pain, pulmonary edema, thrombocytopenia, elevated liver enzymes or creatinine.
3. Preeclampsia with severe features requires urgent admission, magnesium sulfate to prevent seizures, and antihypertensives like hydralazine, labetalol or nifedipine to control blood pressure. The goal is
The kidneys filter waste and excess fluid from the blood. As kidneys fail, waste builds up.
Symptoms develop slowly and aren't specific to the disease. Some people have no symptoms at all and are diagnosed by a lab test.
Medication helps manage symptoms. In later stages, filtering the blood with a machine (dialysis) or a transplant may be required.
Although the most important causes of kidney injury in late pregnancy are preeclampsia and the associated disorders eclampsia and HELLP (hemolysis, elevated liver enzyme levels, low platelet count) syndrome, they will be discussed with the hypertensive disorders of pregnancy.
This document discusses hypertensive disorders in pregnancy. It begins by defining hypertensive disorders and noting their high rates of morbidity and mortality. It then discusses the various types of hypertensive disorders seen in pregnancy (gestational hypertension, preeclampsia, eclampsia, chronic hypertension, etc.) and their signs and symptoms. Risk factors are identified. The pathophysiology and assessment/management of hypertensive disorders are explained in detail over multiple pages. Management includes antihypertensive treatment, seizure prophylaxis, monitoring, delivery indications, and postpartum care. Hypertensive disorders are identified as one of the most significant complications seen in up to 10% of pregnancies.
This document discusses hypertension in pregnancy, including gestational hypertension. It defines gestational hypertension as blood pressure of 140/90 or higher after 20 weeks of pregnancy without proteinuria, with blood pressure returning to normal within 12 weeks postpartum. It notes that early onset of gestational hypertension and higher blood pressure are risk factors for progression to preeclampsia. Treatment for gestational hypertension focuses on monitoring and controlling severe high blood pressure, with delivery occurring between 37-38 weeks.
P R E G N A N C Y I N D U C E D H Y P E R T E N S I O NDr. Shaheer Haider
Pregnancy-induced hypertension (PIH) is defined as new hypertension developing after 20 weeks of gestation. It affects 5-8% of pregnancies and can range from mild to severe, including pre-eclampsia and eclampsia. The exact cause is unknown but may involve immunological and endothelial dysfunction factors. Treatment aims to prevent complications and involves bed rest, magnesium sulfate, antihypertensive drugs, and delivery if gestation reaches term or the mother/baby's condition deteriorates.
Hypertensive disorders in pregnancy are a leading cause of maternal and fetal morbidity and mortality in India. It is characterized by new onset hypertension and proteinuria after 20 weeks of gestation. The disorder includes gestational hypertension, preeclampsia, and preeclampsia superimposed on chronic hypertension. Symptoms include headaches, visual disturbances, and right upper quadrant pain. Management involves hospitalization, bed rest, blood pressure monitoring, magnesium sulfate administration to prevent seizures, and often early delivery. Untreated hypertensive disorders can lead to serious maternal complications like eclampsia and organ damage as well as fetal growth restriction and death.
A 38 slide power-point presentation for medical students years 4 or 5. The idea to familiarize with classification, clinical features, diagnosis and management.
The document outlines the diagnosis, classification, risk factors, complications and management of hypertensive disorders in pregnancy, focusing on pre-eclampsia. It defines pre-eclampsia and how it is diagnosed, classified as mild, moderate or severe based on symptoms and signs. The management of pre-eclampsia is also described, including controlling blood pressure, seizures and fluid balance, as well as delivering the baby.
HYPERTENSIVE DISORDER IN PREGNANCY.pptxHannatAboud
This document discusses hypertensive disorders in pregnancy, including preeclampsia. It defines the different types of hypertension during pregnancy and outlines risk factors and pathophysiology of preeclampsia. The key theories around the abnormal trophoblastic invasion and immunological and vasoconstrictor/vasodilator imbalances are summarized. Diagnosis, management including controlling blood pressure, preventing eclampsia and timely delivery, and potential complications are covered at a high level. Management involves careful monitoring, controlling hypertension and seizures, delivering the baby when indicated based on gestational age and severity of symptoms, and following up postpartum.
This document discusses pregnancy induced hypertension (PIH), also known as preeclampsia. PIH is a multisystem disorder of unknown etiology that can lead to increased maternal and fetal morbidity and mortality if left untreated. It is characterized by new onset hypertension and proteinuria after 20 weeks of gestation. The document covers the classification, signs, symptoms, risk factors, pathophysiology, diagnosis and management of the different types of PIH, including chronic hypertension, gestational hypertension, preeclampsia, and eclampsia. Treatment involves blood pressure control with antihypertensives, magnesium sulfate to prevent seizures, and timely delivery once the fetus is mature.
This document discusses pregnancy induced hypertension (PIH), including definitions, classifications, risk factors, pathophysiology, diagnosis, and management. PIH is a multisystem disorder characterized by new onset hypertension after 20 weeks of gestation. It includes gestational hypertension, preeclampsia, and eclampsia. Management involves monitoring for signs of worsening disease and delivering after 37 weeks if mild or earlier if severe to prevent maternal and fetal morbidity and mortality. Treatment includes antihypertensives, magnesium sulfate to prevent seizures, and delivery.
The document defines and classifies hypertensive disorders in pregnancy including gestational hypertension, preeclampsia, eclampsia, and chronic hypertension. It describes the risk factors, diagnosis, and management of these conditions. Key points include:
- Preeclampsia is defined as new onset hypertension and proteinuria after 20 weeks of gestation.
- Magnesium sulfate is the primary treatment for preventing seizures in preeclampsia and eclampsia.
- Delivery is usually indicated for preeclampsia between 28-37 weeks of gestation or by term for control of maternal symptoms and blood pressure.
Pregnancy complications can include pregnancy-induced hypertension (PIH), preeclampsia, and gestational hypertension. Preeclampsia is characterized by high blood pressure and excess protein in the urine after 20 weeks of pregnancy. It can threaten the health of both mother and baby. Risk factors include a personal or family history of preeclampsia, obesity, young or advanced maternal age, multiple gestation, and certain genetic factors. Treatment focuses on delivering the baby to resolve preeclampsia, along with controlling blood pressure and monitoring for serious complications.
04_Modern problems of pregnancy induced hypertension-2019.pptxUgo161BB
1. Gestoses and hypertensive disorders are common and serious conditions in obstetrics that can cause morbidity and mortality for both mother and fetus.
2. The document discusses various classifications of gestational problems including early pregnancy issues like ptyalism (excessive salivation), nausea, vomiting, and rare forms like hyperemesis gravidarum. It also covers pregnancy-induced hypertension, preeclampsia, eclampsia and their risk factors and pathophysiology.
3. Diagnosis and management of conditions like gestational hypertension and preeclampsia are outlined, including diagnostic criteria, symptoms, laboratory abnormalities and tests. Complications and maternal and fetal monitoring are also addressed.
This document discusses eclampsia, a severe complication of preeclampsia characterized by new onset seizures. It provides information on the pathophysiology, signs and symptoms, risk factors, diagnosis, and management of eclampsia. Eclampsia is caused by high blood pressure resulting in seizures during pregnancy. It affects about 1 in 200 women with preeclampsia. Treatment decisions consider severity, gestational age, and risks to both mother and fetus. Management may involve medical treatment to control blood pressure as well as induction of labor or cesarean section to deliver the baby, which is the only cure for eclampsia.
Jeff Rundio, DO- OB Board Review 2014 - ARMC Emergency MedicineTroy Pennington
This document summarizes several key physiological changes that occur during pregnancy and some common complications. It notes increased cardiac output, blood volume, and insulin resistance during pregnancy. Common complications discussed include vaginal bleeding, miscarriage, ectopic pregnancy, abruptio placentae, placenta previa, uterine rupture, preeclampsia, postpartum bleeding, endometritis, and mastitis. It provides diagnostic criteria and management guidelines for evaluating and treating these complications.
10 Benefits an EPCR Software should Bring to EMS Organizations Traumasoft LLC
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
DECLARATION OF HELSINKI - History and principlesanaghabharat01
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
This document discusses hypertension in pregnancy, including gestational hypertension and preeclampsia. It defines the different categories of hypertension in pregnancy, describes the pathophysiology and risk factors, and outlines treatment and management approaches. Key points include that hypertension complicates 8% of pregnancies and is a leading cause of maternal mortality. Gestational hypertension is defined as hypertension after 20 weeks in a previously normotensive woman that resolves by 12 weeks postpartum, while preeclampsia involves hypertension and proteinuria. Early onset of gestational hypertension or higher blood pressure levels increase the risk of progression to preeclampsia. Treatment focuses on controlling blood pressure, preventing seizures with magnesium sulfate, and timely delivery.
Gestational hypertension is defined as hypertension occurring for the first time after 20 weeks of pregnancy with NO proteinuria or other features of preeclampsia.
The correct answer is 4.
Hypertension in pregnancy can be gestational hypertension, chronic hypertension, or chronic hypertension appearing for the first time in pregnancy. Gestational hypertension is high blood pressure without proteinuria after 20 weeks of gestation. Pre-eclampsia includes gestational hypertension plus proteinuria. Eclampsia involves seizures in pre-eclamptic women. The pathophysiology involves placental lesions restricting blood flow and damaging the endothelium, affecting multiple maternal organs. Management involves monitoring, controlling blood pressure, delivering if complications occur, and magnesium sulfate to prevent seizures in eclampsia.
Hypertensive disorder during pregnancy.pptxMesfinShifara
1. Gestational hypertension is defined as new hypertension after 20 weeks without proteinuria. It is managed as an outpatient by monitoring blood pressure and fetal wellbeing.
2. Preeclampsia is defined as new hypertension and proteinuria after 20 weeks. It is classified as preeclampsia without or with severe features. Severe features include headaches, visual disturbances, abdominal pain, pulmonary edema, thrombocytopenia, elevated liver enzymes or creatinine.
3. Preeclampsia with severe features requires urgent admission, magnesium sulfate to prevent seizures, and antihypertensives like hydralazine, labetalol or nifedipine to control blood pressure. The goal is
The kidneys filter waste and excess fluid from the blood. As kidneys fail, waste builds up.
Symptoms develop slowly and aren't specific to the disease. Some people have no symptoms at all and are diagnosed by a lab test.
Medication helps manage symptoms. In later stages, filtering the blood with a machine (dialysis) or a transplant may be required.
Although the most important causes of kidney injury in late pregnancy are preeclampsia and the associated disorders eclampsia and HELLP (hemolysis, elevated liver enzyme levels, low platelet count) syndrome, they will be discussed with the hypertensive disorders of pregnancy.
This document discusses hypertensive disorders in pregnancy. It begins by defining hypertensive disorders and noting their high rates of morbidity and mortality. It then discusses the various types of hypertensive disorders seen in pregnancy (gestational hypertension, preeclampsia, eclampsia, chronic hypertension, etc.) and their signs and symptoms. Risk factors are identified. The pathophysiology and assessment/management of hypertensive disorders are explained in detail over multiple pages. Management includes antihypertensive treatment, seizure prophylaxis, monitoring, delivery indications, and postpartum care. Hypertensive disorders are identified as one of the most significant complications seen in up to 10% of pregnancies.
This document discusses hypertension in pregnancy, including gestational hypertension. It defines gestational hypertension as blood pressure of 140/90 or higher after 20 weeks of pregnancy without proteinuria, with blood pressure returning to normal within 12 weeks postpartum. It notes that early onset of gestational hypertension and higher blood pressure are risk factors for progression to preeclampsia. Treatment for gestational hypertension focuses on monitoring and controlling severe high blood pressure, with delivery occurring between 37-38 weeks.
P R E G N A N C Y I N D U C E D H Y P E R T E N S I O NDr. Shaheer Haider
Pregnancy-induced hypertension (PIH) is defined as new hypertension developing after 20 weeks of gestation. It affects 5-8% of pregnancies and can range from mild to severe, including pre-eclampsia and eclampsia. The exact cause is unknown but may involve immunological and endothelial dysfunction factors. Treatment aims to prevent complications and involves bed rest, magnesium sulfate, antihypertensive drugs, and delivery if gestation reaches term or the mother/baby's condition deteriorates.
Hypertensive disorders in pregnancy are a leading cause of maternal and fetal morbidity and mortality in India. It is characterized by new onset hypertension and proteinuria after 20 weeks of gestation. The disorder includes gestational hypertension, preeclampsia, and preeclampsia superimposed on chronic hypertension. Symptoms include headaches, visual disturbances, and right upper quadrant pain. Management involves hospitalization, bed rest, blood pressure monitoring, magnesium sulfate administration to prevent seizures, and often early delivery. Untreated hypertensive disorders can lead to serious maternal complications like eclampsia and organ damage as well as fetal growth restriction and death.
A 38 slide power-point presentation for medical students years 4 or 5. The idea to familiarize with classification, clinical features, diagnosis and management.
The document outlines the diagnosis, classification, risk factors, complications and management of hypertensive disorders in pregnancy, focusing on pre-eclampsia. It defines pre-eclampsia and how it is diagnosed, classified as mild, moderate or severe based on symptoms and signs. The management of pre-eclampsia is also described, including controlling blood pressure, seizures and fluid balance, as well as delivering the baby.
HYPERTENSIVE DISORDER IN PREGNANCY.pptxHannatAboud
This document discusses hypertensive disorders in pregnancy, including preeclampsia. It defines the different types of hypertension during pregnancy and outlines risk factors and pathophysiology of preeclampsia. The key theories around the abnormal trophoblastic invasion and immunological and vasoconstrictor/vasodilator imbalances are summarized. Diagnosis, management including controlling blood pressure, preventing eclampsia and timely delivery, and potential complications are covered at a high level. Management involves careful monitoring, controlling hypertension and seizures, delivering the baby when indicated based on gestational age and severity of symptoms, and following up postpartum.
This document discusses pregnancy induced hypertension (PIH), also known as preeclampsia. PIH is a multisystem disorder of unknown etiology that can lead to increased maternal and fetal morbidity and mortality if left untreated. It is characterized by new onset hypertension and proteinuria after 20 weeks of gestation. The document covers the classification, signs, symptoms, risk factors, pathophysiology, diagnosis and management of the different types of PIH, including chronic hypertension, gestational hypertension, preeclampsia, and eclampsia. Treatment involves blood pressure control with antihypertensives, magnesium sulfate to prevent seizures, and timely delivery once the fetus is mature.
This document discusses pregnancy induced hypertension (PIH), including definitions, classifications, risk factors, pathophysiology, diagnosis, and management. PIH is a multisystem disorder characterized by new onset hypertension after 20 weeks of gestation. It includes gestational hypertension, preeclampsia, and eclampsia. Management involves monitoring for signs of worsening disease and delivering after 37 weeks if mild or earlier if severe to prevent maternal and fetal morbidity and mortality. Treatment includes antihypertensives, magnesium sulfate to prevent seizures, and delivery.
The document defines and classifies hypertensive disorders in pregnancy including gestational hypertension, preeclampsia, eclampsia, and chronic hypertension. It describes the risk factors, diagnosis, and management of these conditions. Key points include:
- Preeclampsia is defined as new onset hypertension and proteinuria after 20 weeks of gestation.
- Magnesium sulfate is the primary treatment for preventing seizures in preeclampsia and eclampsia.
- Delivery is usually indicated for preeclampsia between 28-37 weeks of gestation or by term for control of maternal symptoms and blood pressure.
Pregnancy complications can include pregnancy-induced hypertension (PIH), preeclampsia, and gestational hypertension. Preeclampsia is characterized by high blood pressure and excess protein in the urine after 20 weeks of pregnancy. It can threaten the health of both mother and baby. Risk factors include a personal or family history of preeclampsia, obesity, young or advanced maternal age, multiple gestation, and certain genetic factors. Treatment focuses on delivering the baby to resolve preeclampsia, along with controlling blood pressure and monitoring for serious complications.
04_Modern problems of pregnancy induced hypertension-2019.pptxUgo161BB
1. Gestoses and hypertensive disorders are common and serious conditions in obstetrics that can cause morbidity and mortality for both mother and fetus.
2. The document discusses various classifications of gestational problems including early pregnancy issues like ptyalism (excessive salivation), nausea, vomiting, and rare forms like hyperemesis gravidarum. It also covers pregnancy-induced hypertension, preeclampsia, eclampsia and their risk factors and pathophysiology.
3. Diagnosis and management of conditions like gestational hypertension and preeclampsia are outlined, including diagnostic criteria, symptoms, laboratory abnormalities and tests. Complications and maternal and fetal monitoring are also addressed.
This document discusses eclampsia, a severe complication of preeclampsia characterized by new onset seizures. It provides information on the pathophysiology, signs and symptoms, risk factors, diagnosis, and management of eclampsia. Eclampsia is caused by high blood pressure resulting in seizures during pregnancy. It affects about 1 in 200 women with preeclampsia. Treatment decisions consider severity, gestational age, and risks to both mother and fetus. Management may involve medical treatment to control blood pressure as well as induction of labor or cesarean section to deliver the baby, which is the only cure for eclampsia.
Jeff Rundio, DO- OB Board Review 2014 - ARMC Emergency MedicineTroy Pennington
This document summarizes several key physiological changes that occur during pregnancy and some common complications. It notes increased cardiac output, blood volume, and insulin resistance during pregnancy. Common complications discussed include vaginal bleeding, miscarriage, ectopic pregnancy, abruptio placentae, placenta previa, uterine rupture, preeclampsia, postpartum bleeding, endometritis, and mastitis. It provides diagnostic criteria and management guidelines for evaluating and treating these complications.
10 Benefits an EPCR Software should Bring to EMS Organizations Traumasoft LLC
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
DECLARATION OF HELSINKI - History and principlesanaghabharat01
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
2. CLASSIFICATION OF HYPERTENSION DURING
PREGNANCY
First four are the main categories of hypertension
During Pregnancy
1. Preeclampsia
2. Eclampsia
3. Gestational hypertension
4. Chronic hypertension
5. Preeclampsia superimposed on chronic
hypertension
See table 25-1 (classification of hypertension in
pregnancy), page 591
2
3. GESTATIONAL HYPERTENSION
Blood pressure elevation (Systolic ≥ 140 mmHg
or diastolic ≥ 90 mmHg) after 20 weeks of
pregnancy, that is not accompanied by
proteinurea and returns to normal within 6
weeks postpartum.
proteinuria is not present (negative or trace)
3
4. PREECLAMPSIA
Systolic blood pressure of 140
mmHg or more and diastolic
blood pressure of 90 mmHg or
more after 20 weeks of
pregnancy that is accompanied
by proteinurea more or equal
0.3 g in a 24 hour collection or
1+ or more in random urine
dipstick 4
6. CHRONIC HYPERTENSION
Elevated blood pressure that
was known to exist before
pregnancy or develops before
20 weeks of pregnancy or
hypertension that is not
resolved during postpartum
period
6
7. PREECLAMPSIA SUPERIMPOSED ON CHRONIC
HYPERTENSION
Development of new onset proteinurea more or equal
0.3 g in a 24 hour collection or 1+ or more in random
urine dipstick in a woman who has chronic
hypertension. In a woman who had proteinuria before
20 weeks of gestation,
Preeclampsia should be suspected if woman has
sudden increase in proteinuria from baseline levels, a
sudden increase in blood pressure when it had been
previously well controlled.
Development of thrombocytopenia (Platelets
<100,000/mm³) , or abnormal elevations of liver
enzymes (Aspartate aminotransferase (AST, (SGOT) )
or Alanine aminotransferase (ALT (SGPT))
7
8. RISK FACTORS
1.First pregnancy
2.Women older than 35 years.
3.Ethnicity (African- American)
4.Positive family history
5.Women who have chronic
hypertension or renal disease.
Cont. 8
9. RISK FACTORS CONT.
6. Overweight
7. Women with DM
8. Multifetal gestations
9. Presence of immunologic disorders.
10.Women married from fathers who has
previously fathered a pregnancy in
another woman that was complicated
with preeclampsia.
9
10. PATHOPHYSIOLOGY
Preeclampsia is a result of
generalized vasospasm
Vasoconstriction results in the
impeded blood flow and elevated
blood pressure. As a result,
circulation to all body organs,
including the kidneys, liver, brain
and placenta is decreased.
10
11. The most significant changes
Decrease Renal Perfusion lead
to
Decreased GFR
Increased (BUN, Createnine, uric
acid)
Proteinurea
Generalized edema +4
Increased blood viscosity (elevated
hematocrite)
Water and sodium retention, rapid
weight gain 11
12. Decreased liver Perfusion
lead to
Impaired liver function
Hepatic edema and
subscapular hemorrhage
Elevated liver enzymes
Epigastric pain
12
13. VASOCONSTRICTION OF CEREBRAL VESSELS
LEAD TO
Cerebral hemorrhage
Headache
visual disturbances (blurred
vision and spot before eyes)
Hyperreflexia
13
14. DECREASED PLACENTAL PERFUSION
LEAD TO
Intra uterine growth restriction
Persistent fetal hypoxemia
Abruptio placenta and HELLP
syndrome(H:Hemolysis, EL: Elevated
liver Enzymes (AST and ALT), LP: Low
platelets counts <100,000/mm³)
May results in DIC
Lung
Pulmonary edema ( symptoms
include dyspnea
14
15. Preventive measures:
1. Early and regular prenatal care
2. Monitor Weight gain
3. Monitor blood pressure
4. Monitoring of urinary protein
5. Anti oxidants therapy:
6. Recent researches assessed the benefit
of 1000mg of Vit C and 400 IU of Vit E
starting at 22 weeks.
7. Attempts of prevention in woman of
high risks. Cont.
15
16. ATTEMPTS OF PREVENTION IN WOMAN OF
HIGH RISKS INCLUDES
a) low dose aspirin
b) Calcium and
magnesium supplement
c) Fish oil supplements
16
17. MANIFESTATIONS:CLASSIC SIGNS:
HYPERTENSION & PROTEINUREA
17
Systolic BP≥140 but
< 160 mm Hg
Diastolic BP ≥ 90
but < 110 mm Hg
Proteinuria ≥0.3g
but <2g in 24hr
collection
1+ or higher on
random dipstick
sample
Systolic BP ≥160
mm Hg
Diastolic BP ≥110
mm Hg
Proteinuria ≥5g in
24hr collection
3+ or higher on
random dipstick
sample
Mild preeclampsia Severe preeclampsia
19. Symptoms: (severe preeclampsia)
Continuous headache
Drowsiness
Mental confusion
Convulsion (Eclampsia)
Visual disturbances
Epigastric pain
Decreased urinary output < 500ml/
day or 30 ml/hr.(oligurea)
See table 25-3 (mild vs. severe
preeclampsia) page 594
19
20. Therapeutic Management:
Delivery is the only definitive
treatment but it may not be
practical if preeclampsia is mild
and the fetus is premature.
If the fetus less than 34 wks,
steroids to accelerate fetal lung
maturity will be given and delay
birth for 48 hrs.
20
21. If the maternal or fetal
condition deteriorates, the
woman will be delivered
regardless the fetal age or
administration of steroids.
Vaginal birth is preferred
because of the multisystem
impairments.
21
22. Home care for mild preeclampsia:
Home management is possible if
1.Preeclampsia is mild
2.The woman and the fetus in
stable condition
3.The woman can adhere to the
treatment plan
4.The woman make a follow up
visit every 3-4 days
22
23. CARE AT HOME
Activity restriction; side lying
at least one and half hour a
day
Fetal activity (kick count)
should report if no movement
noticed in a 4 hour period
Weight daily each morning 23
24. Urinanalysis for proteinurea
daily
Diet, regular balance nutrition
without salt or fluid
restrictions
Blood pressure checked 2 to 4
times daily
24
25. Inpatient management for
severe Preeclampsia:
Severe preeclampsia is diagnosed
if systolic Bp ≥ 160 or diastolic
≥110mmHg or multisystem
involvement
Delivery is necessary even if GW
less than 34
25
26. MANAGEMENT FOR SEVERE
PREECLAMPSIA
Bed rest on quiet environment
Reduce external stimuli that precipitate convulsion
(noise, light)
Anticonvulsant medications (MgSo4)
Antihypertensive medications: If BP
≥ 160/110 Hydralazine is given.
26
27. S/S OF MAGNESIUM SULFATE TOXICITY
Respiratory rate < 12 per minute
Maternal pulse oximetre <95%
Hyporeflexia (absence DTR)
Sweating, flushing
Altered sensory (confusion and
drowsiness
Hypotension
Sudden decrease in FHR
Serum MgSo4 level >8 mg/dl
Urine output<30 ml /hour 27
28. Intrapartum Management:
Monitor the mother to prevent
convulsions
Keep woman on lateral position
Vaginal births is usually the first choice
Give oxytocin to stimulate birth
Continuous fetal monitoring
Pain control (narcotic or epidural)
Mgso4 to prevent convulsion
28
29. Postpartum management:
Careful assessment of the mother’s
blood loss and signs of shock
Assessment of s/s of preeclampsia is
continuous for at least 48 hrs
Continue giving magnesium to
prevent seizures
29
30. Signs of recovering:
Urinary output 4-6 L/day
Decrease protein in urine
Return BP to normal within 2 weeks.
Gradual improvement in serum
laboratory values
30
31. Nursing care
1. Assessment:
Weight daily
Vital signs every 4 hour
Ascultate the chest for moist breath sounds
(pulmonary edema)
Assess edema every 4 hours
Measure urine output hourly
Check urine for protein every 4 hours
31
32. ASSESSMENT OF EDEMA
(+1) Minimal edema of lower
extremities
(+2) Marked edema of lower extremities
(+3) Edema of lower extremities, face,
hands and sacral area
(+4) Generalized massive edema that
include ascites (accumulation of fluid in
peritoneal cavity)
32
34. Fetal monitoring
Check brachial, radial and patellar
reflexes for hyperreflexia, or
hyporeflexia which indicate
magnesium excess
Ask woman about symptoms e.g.
headache, visual disturbances
epigastric pain, nausea vomiting and
increased edema.
34
35. Management of Eclampsia:
Maintain patent airway
Adequate oxygenation
Put the patient on lateral position to
prevent aspiration
After convulsion suction of food and
fluids
Administer anticonvulsant
Monitor fetal status
Blood specimen for type and Rh
Accurate assessment of urine output.
35
36. HELLP SYNDROME
H: Hemolysis
EL: Elevated liver Enzymes (AST and
ALT)
LP: Low platelets counts <100,000/mm³
The Prominent Symptoms:
Pain in the right upper quadrant, the
lower chest or epigastric area
Nausea, vomiting and severe edema
Treatment in intensive care unit
36